Testosterone Therapy for Women

Testosterone therapy for women exists in a unique regulatory position. It's not officially approved for women in most countries, yet it's increasingly prescribed off-label, and growing evidence supports its use for specific symptoms. Understanding what testosterone does, what research shows, and what considerations matter helps you make informed decisions if this option is suggested.

Testosterone's Role in Women

Testosterone is often considered a male hormone, but women produce testosterone throughout their lives. Your ovaries produce testosterone, and your adrenal glands produce the precursor DHEA which is converted to testosterone. While women produce far less testosterone than men, the hormone is important for sexual function, energy, muscle health, and wellbeing.

At reproductive age, women produce about 15 to 70 nanograms per deciliter of testosterone, though this varies. After menopause, testosterone production drops substantially, often to below 15 nanograms per deciliter. Some women's testosterone drops even lower.

Testosterone influences sexual arousal and responsiveness. It affects clitoral sensitivity and the engorgement of genital tissues. It supports lubrication indirectly by affecting vascular function and supporting tissue health. It influences sexual motivation and desire.

Beyond sexuality, testosterone supports muscle mass, strength, and bone density. It contributes to energy and motivation. It influences mood, cognitive function, and sense of wellbeing. Some women report that testosterone therapy improves their sense of confidence and assertiveness.

When Testosterone Decline Becomes Problematic

Testosterone naturally declines in menopause. Some women tolerate this decline with minimal symptoms. Others experience significant sexual dysfunction, profound fatigue, or loss of motivation that substantially affects quality of life.

Low libido is the most common symptom driving women to consider testosterone therapy. This may involve reduced sexual interest, reduced arousal, or difficulty with orgasm. The decline in testosterone contributes to these changes, though it's not the only factor. Estrogen decline, progesterone withdrawal, relationship factors, body image, mood, and fatigue all influence libido.

Fatigue in menopause is sometimes called "post-menopausal fatigue" when it persists despite hormone replacement therapy. Some women describe a distinct energy deficit, feeling depleted without obvious cause. Testosterone may contribute to this fatigue in some women.

Some women report reduced motivation, difficulty initiating activities, or loss of competitive drive. While this overlaps with depression, some women with testosterone therapy report that this specific type of motivational loss improves.

Evidence for Testosterone Therapy

Research on testosterone therapy in women is less extensive than research on estrogen therapy, partly because testosterone therapy remains off-label and not uniformly approved for women. However, existing evidence provides useful information.

Studies of testosterone therapy in postmenopausal women with low libido show improved sexual desire and improved sexual satisfaction in roughly 50 to 60 percent of women studied. Improvements are most pronounced for women with clearly low testosterone levels, though individual response varies even among women with similar baseline levels.

Testosterone therapy may improve energy and motivation in some women, though evidence is less robust than for sexual function. Some women report substantial improvement; others notice minimal change.

Research on testosterone's effects on muscle and bone in women is more limited, partly because bone health in menopause is typically addressed with estrogen therapy and other approaches. Some evidence suggests testosterone supports muscle mass and bone density, but women's studies are less extensive than men's.

Dosing and Delivery

Testosterone therapy for women uses much lower doses than men's testosterone therapy. Typical doses range from 0.25 to 2 milligrams daily, compared to typical male dosing of 50 to 100 milligrams or more.

Testosterone can be delivered through several routes. Oral testosterone is available in some countries but isn't standard, partly because oral absorption is variable and affects liver function. Transdermal testosterone patches deliver steady hormone through the skin. Testosterone gels or creams allow some dose adjustment. Some compounding pharmacies create custom testosterone preparations in various forms.

Subcutaneous testosterone implants, common in Australian and some European practices, place a small implant under the skin that releases testosterone steadily over several months. These avoid daily medication but require insertion and removal procedures.

Topical testosterone is increasingly available in women-specific doses and formulations. The advantage of topical therapy is steady absorption and the ability to adjust dose. The disadvantage is that topical testosterone absorption varies based on skin thickness and hydration.

Most evidence supporting benefit comes from studies using transdermal or implant testosterone, rather than oral forms.

Who Benefits Most

Women most likely to benefit from testosterone therapy are those with all of the following: clearly reduced sexual desire or difficulty with arousal despite adequate estrogen therapy, measured low testosterone levels, and absence of contraindications. The specificity matters because not every woman with low testosterone levels has symptoms, and not every woman with low libido responds to testosterone.

Women who've had their ovaries surgically removed often have very low testosterone and may benefit from testosterone therapy. Similarly, women whose testosterone is suppressed by other treatments sometimes benefit from replacement.

Women with normal or high testosterone levels are unlikely to benefit from additional testosterone. Similarly, women whose low libido stems entirely from relationship problems or depression may not benefit if testosterone isn't the limiting factor.

Potential Side Effects and Monitoring

Side effects of testosterone therapy in women are generally modest at the doses used, but they do occur. Virilization, the development of male characteristics, can occur with excessive testosterone. This includes deepening of the voice, increased facial or body hair, male-pattern hair loss, and clitoral enlargement. The risk is lower with appropriate women's dosing, but the possibility exists.

Acne and oily skin sometimes occur. Mood changes can happen, though whether this represents improvement or worsening depends on the individual. Some women report increased confidence and assertiveness, which they appreciate. Others experience increased irritability. Individual variation is substantial.

Testosterone therapy increases red blood cell production slightly, which could theoretically increase cardiovascular risk, though evidence in women at appropriate doses is reassuring. Testosterone may slightly increase LDL cholesterol and decrease HDL cholesterol in some women, though changes are typically modest.

Monitoring while on testosterone involves periodic testosterone level checks to ensure dosing is appropriate, baseline lipid testing and periodic follow-up, liver function testing, and monitoring for any virilization signs. Some practitioners monitor hematocrit to watch for excessive red blood cell production.

Cardiovascular and Cancer Considerations

The cardiovascular safety of testosterone therapy in women is increasingly clear. The doses used in women's therapy are much lower than doses that caused problems in old men's studies, and the risk profile is different. Current evidence doesn't suggest cardiovascular risk from appropriate testosterone therapy in women.

Cancer risk is a more nuanced consideration. Testosterone itself isn't clearly carcinogenic, but it's converted to estrogen in the body. For women with a history of hormone-sensitive cancers, the additional estrogen from testosterone conversion could theoretically increase recurrence risk. Most practitioners recommend caution with testosterone therapy in women with a history of breast cancer, though some use it carefully with close monitoring.

Evidence that testosterone increases endometrial cancer risk is lacking. For ovarian cancer, testosterone therapy history is an uncommon enough scenario that evidence is sparse, but testosterone isn't typically contraindicated in ovarian cancer survivors.

Long-term Use

Long-term safety data on testosterone therapy in women is limited because the therapy is relatively recent and off-label. Most women studying testosterone therapy use it for several years, though some use it longer. Regular monitoring is appropriate, particularly for women using testosterone indefinitely.

Some women use testosterone therapy only temporarily, during the most symptomatic menopausal years, then discontinue. Others use it long-term. Individual preference, tolerance, and efficacy guide these decisions.

Regulatory Status and Access

The regulatory landscape for testosterone therapy in women varies by country. In some countries, testosterone therapy for women is approved and standardized. In others, including the United States, it remains off-label, available through compounding pharmacies or research protocols.

This off-label status doesn't mean it's unsafe or ineffective. Many standard medical practices are off-label. However, it means insurance typically doesn't cover it, costs can be higher, and there's less standardization in what's offered.

The European Medicines Agency, in some countries, has approved testosterone therapy for specific indications in women. As evidence accumulates, regulatory approval in other countries may expand.

The Relationship with Estrogen Therapy

Testosterone therapy often works better when combined with adequate estrogen therapy. Estrogen supports vaginal and clitoral tissue health, improving conditions for testosterone to work. Additionally, estrogen's mood-supporting and energy-supporting effects create a foundation upon which testosterone can be more effective.

Women on hormone replacement therapy without testosterone who still experience low libido or fatigue might benefit from adding testosterone. Conversely, testosterone alone, without adequate estrogen replacement, is rarely optimal.

Individual Decision-Making

If testosterone therapy is suggested for you, weighing individual benefits and risks matters. Questions worth considering include: Have you optimized estrogen and progesterone therapy first? Is your low libido or fatigue actually low, or is it normal for your age and stage of life? Are there non-hormonal factors affecting your symptoms that should be addressed first, such as relationship issues or depression?

Does the symptom you're hoping to treat actually respond to testosterone? Some symptoms improve predictably; others are variable. Your practitioner's experience with testosterone therapy and confidence in matching it to appropriate candidates matters significantly.

Are you willing to accept potential side effects in exchange for potential benefits? For some women, the benefit is transformative. For others, it's modest or absent. Predicting individual response is difficult.

Testosterone therapy for women represents an increasingly available option for specific menopause-related symptoms. When appropriately selected, dosed, and monitored, evidence supports its use. Like all treatments, it's not appropriate for everyone, and careful consideration of individual circumstances guides whether it's right for you.